| ISTODAX Celgene Corporation
79058882 22 Aug 2008 | on 09 Apr 2018
| Color is not claimed as a feature of the mark.,Pharmaceutical preparat... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | ONCRUZO Celgene Corporation
88685646 08 Nov 2019 | on 06 Jan 2020 | Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharma... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of blood disease and cancer | | | EMCRUZO Celgene Corporation
88685617 08 Nov 2019 | on 06 Jan 2020 | Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharma... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of blood disease and cancer | | | PLEIOTROPIC PATHWAY MODIFIER Celgene Corporation
87161716 06 Sep 2016 | on 20 Jun 2017 | chemical preparations for pharmaceutical purposes, namely, for the tre... Class 001 Class 001 Chemical Products chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and inflammatory diseases Class 005 Class 005 Pharmaceutical Products biomedical compounds, namely, peptide substrates with anti-tumor and immuno modulatory activity used in analyzing and detecting certain toxins used for laboratory or research use in developing pharmaceuticals for use in the field of oncology and inflammatory diseases | | | IDHIPLI Celgene Corporation
87143228 18 Aug 2016 | on 19 Jan 2024 | Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | | CIZMEDA Celgene Corporation
87143183 18 Aug 2016 | on 19 Jan 2024 | Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | | TEMNIKA Celgene Corporation
87143159 18 Aug 2016 | on 26 Jan 2024 | Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | | ROVIVZEL Celgene Corporation
87143093 18 Aug 2016 | on 13 Mar 2017 | Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | | IDHIGA Celgene Corporation
87143200 18 Aug 2016 | on 19 Jan 2024 | Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | | VIZIDH Celgene Corporation
87143137 18 Aug 2016 | on 26 Jan 2024 | Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | 
